RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...

AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical ...

Xponance Inc. grew its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 23.1% during the fourth ...

PNC Financial Services Group Inc. lessened its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 8.9 ...

CorMedix today reports its second full quarter of DefenCath sales since commencing outpatient launch in July 2024 and first partial year of DefenCath sales. The Company reported net sales of $31.2 ...

Benitec Biopharma (NASDAQ:BNTC) is looking to raise around $30M in gross proceeds via its securities offerings. The biotechnology company is selling 1,443,000 shares of its common stock (or pre-funded ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 11.76%, which has investors questioning if this is right time to sell.

Fortunately, the S&P 500 recovered to new all-time highs by August 2020 and is now up about 150% from its COVID lows.

NeuroNOS, a pioneering biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and other complex neurological conditions, including Alzheimer's ...

Samsung E&A (Seoul, South Korea) has won a contract for the main construction of the Songdo Bio Raw Materials Plant from ...

Shares of CorMedix Tuesday dropped after the company's outlook for the first half of 2025 disappointed investors despite beating expectations in the fourth quarter. The stock was down 31% at $7.39 in ...